Remote patient monitoring will accelerate diagnosis while reducing costs. The information system must access all information that is pertinent to patient diagnosis. The patient right-to-try law will accelerate the clinical trials of genetic treatments. Genomic counseling from the researcher is required for the patient and physician to identify the risk of treatment and adverse drug effects. Genetic data is essential to timely diagnosis.
The security of information is critically important to many patients. Genetic information must be protected from disclosure to the public. Intellectual property must protect the value and investment in development.
The information system must be interoperable with the practicing physician, specialist physician, medical laboratory, pharmacy, hospital, clinic, and insurer.
